View drug registration information details.
| Items | Registration information |
|---|
| ID | 546 |
|---|
| No | 546 |
|---|
| Brand Name | OGIVRI 440 |
|---|
| Ingredients | TRASTUZUMAB 440 MG |
|---|
| Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 4 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL/440 MG |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | ADJUVANT BREAST CANCER, MATASTATIC BREAST CANCER, METASTATIC GASTRIC CANCER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | STERILE, OFF WHITE TO PALE YELLOW, PRESERVATIVE-FREE LYOPHILIZED POWDER FOR INJECTION, FOR INTRAVENOUS ADMINISTRATION |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | BIOCON LIMITED |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 I 5440/23 |
|---|
| FDD Registration Date | 31-Mar-2023 |
|---|
| Expiry Date | 30-Mar-2026 |
|---|
Back to drug list
|
